MBRX · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2023-05-10 compared with 2022-11-10 · 0 added, 4 removed, 23 unchanged (15% of the section changed)
OTHER INFORMATION. 
−Removed: EXHIBITS 
−Removed: Portfolio Development Advisor Agreement dated September 6, 2022 between KEWAT, LLC and Moleculin Biotech, Inc.
Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
14 unchanged sentences
MOLECULIN BIOTECH, INC.
−Removed: November 10, 2022
/s/ Walter V.
1 unchanged sentence
(Principal Executive Officer)
−Removed: November 10, 2022
/s/ Jonathan P.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.